Evidence map›Paper›PMID 39622096›Full record

ArticleBiomaterials advances2025

The effect of osteoclasts on epigenetic regulation by long non-coding RNAs in osteoblasts grown on titanium with nanotopography.

Rayana Longo Bighetti-Trevisan, Luciana Oliveira Almeida, Jaqueline Isadora Reis Ramos, Gileade Pereira Freitas, Fabiola Singaretti Oliveira, Jonathan Alexander Robert Gordon, Coralee Elizabeth Tye, Gary Stephen Stein, Jane Barbara Lian, Janet Lee Stein and 2 more

Abstract read
In one paragraph

Article in Biomaterials advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rayana Longo Bighetti-TrevisanBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil; Faculty of Dentistry, University of Ribeirão Preto, Ribeirão Preto, SP, Brazil. Electronic address: rtrevisan@unaerp.br.
Luciana Oliveira AlmeidaBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil; Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: lubio2001@usp.br.
Jaqueline Isadora Reis RamosBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: jaqueline.isadora.ramos@usp.br.
Gileade Pereira FreitasBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil; Department of Oral and Maxillofacial Surgery, School of Dentistry, Federal University of Goiás, Goiânia, GO, Brazil.. Electronic address: gileade@ufg.br.
Fabiola Singaretti OliveiraBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: oliveira@forp.usp.br.
Jonathan Alexander Robert GordonDepartment of Biochemistry and Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America. Electronic address: Jonathan.A.Gordon@med.uvm.edu.
Coralee Elizabeth TyeDepartment of Biochemistry and Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America. Electronic address: Coralee.Tye@med.uvm.edu.
Gary Stephen SteinDepartment of Biochemistry and Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America. Electronic address: Gary.Stein@med.uvm.edu.
Jane Barbara LianDepartment of Biochemistry and Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America. Electronic address: Jane.Lian@med.uvm.edu.
Janet Lee SteinDepartment of Biochemistry and Vermont Cancer Center, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America. Electronic address: Janet.Stein@med.uvm.edu.
Adalberto Luiz RosaBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: adalrosa@forp.usp.br.
Marcio Mateus BelotiBone Research Lab, Ribeirão Preto School of Dentistry, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: mmbeloti@usp.br.

Funding

Understanding Factors Influencing COVID-19 Testing and Vaccination in Immigrant Low-income and Homeless Populations and Testing Targeted InterventionsU54GM115516 · NIGMS · MAINEHEALTH · PI Frances E. Carr · 2017 to 2026
$51.6M
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast CancerP01CA240685 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI STEIN, JANET L · 2021 to 2025
$8.7M
CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Chromatin Organization Regulates OsteogenesisR01DE029311 · NIDCR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI LIAN, JANE B., STEIN, GARY S. · 2020 to 2024
$2.5M
Human lncRNA mediated control of human osteogenesisR01AR084561 · NIAMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Jonathan A.R. Gordon, Gary S. Stein · 2025 to 2026
$1.2M
NCI NIH HHS P01 CA240685NIAMS NIH HHS R01 AR039588NIAMS NIH HHS R01 AR084561NIDCR NIH HHS R01 DE029311NIGMS NIH HHS U54 GM115516
6 · The paper itself

Abstract

Titanium (Ti) implant osseointegration is regulated by the crosstalk among bone cells that are affected by epigenetic machinery, including the regulation of long non-coding RNAs (lncRNAs). Nanotopography Ti (Ti Nano) induces the differentiation of osteoblasts that are inhibited by osteoclasts through epigenetic mechanisms. Thus, we hypothesize that osteoclasts affect lncRNA expression in Ti Nano-cultivated osteoblasts. Osteoblasts were grown on Ti Nano and Ti Control that were then co-cultured with osteoclasts for 48 h. Using RNAseq, we identified 252 modulated lncRNAs in osteoblasts regulated by both surfaces of Ti, but mainly in Ti Nano-cultivated osteoblasts. A negative correlation was observed between Kcnq1ot1 and the mRNAs of Alpl, Bglap, Bmp8a, Col1a1, and Vim in Ti Nano-cultivated osteoblasts with osteoclasts. The pull-down indicated that Bglap mRNA is a direct target of Kcnq1ot1, with enhanced physical interaction in Ti Nano-cultivated osteoblasts, and greater osteoclast inhibition than the Ti Control. The bone marker expression at the levels of mRNA and protein were downregulated by the Kcnq1ot1 silencing, indicating its pivotal role in osteoblast differentiation. These results showed that nanostructured Ti surface modulates the osteoblast-osteoclast crosstalk, at least in part, through the regulation of lncRNA expression in osteoblasts. We demonstrate that the lncRNA Kcnq1ot1 directly interacts with Bglap mRNA, and this interaction is enhanced by nanotopography and reduced by osteoclasts with greater intensity in Ti Nano-cultivated osteoblasts. These findings confirm the molecular mechanisms associated with the high osteogenic potential of nanotopography and can potentially support osteointegration of dental and skeletal prostheses.

Indexed as

Cell DifferentiationEpigenesis, GeneticOsteoblastsOsteoclastsRNA, Long NoncodingTitaniumAnimalsCells, CulturedCoculture TechniquesMiceNanostructuresOsteogenesisSurface PropertiesRNA, Long NoncodingTitaniumBiomaterialBone biologyEpigeneticsOsseointegrationTitanium implant

Identifiers

PMID39622096
PMCPMC11659966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.